iova stock price — Iovance Biotherapeutics (IOVA)
Iovance Biotherapeutics (IOVA) — Stock price
Iovance Biotherapeutics, Inc. is a NASDAQ-listed biotechnology company. This article documents the iova stock price, common market data fields, trading characteristics, and the main factors that influence the share price so readers can find and interpret quotes reliably.
Company overview
Iovance Biotherapeutics develops tumor-infiltrating lymphocyte (TIL) therapies, including commercial product Amtagvi (lifileucel). The company’s business model, pipeline progress and regulatory milestones drive the iova stock price because biotech equities react strongly to clinical, regulatory and commercial news.
Ticker and exchange
Iovance trades under the ticker IOVA on the NASDAQ. Quotes are typically shown in USD for U.S. trading hours. When checking the iova stock price, note pre-market and after-hours sessions in addition to regular NASDAQ hours.
Current price and market data
Market pages report fields you will see when researching the iova stock price: last trade (last price), bid/ask, day range, 52-week range, volume and market capitalization. Primary retail sources that publish these fields include Google Finance, Yahoo Finance, MarketWatch, Finviz and Barchart.
Typical quote fields explained
- Last price / change / percent change: most recent trade and movement versus prior close.
- Volume / average volume: shares traded today and recent trading average—useful for liquidity when assessing iova stock price moves.
- Market cap / shares outstanding / float: basic size and supply metrics used to contextualize price.
Historical price performance
Historical daily, weekly and monthly price series and returns (YTD, 1Y, multi-year) are available on finance portals and can be downloaded for charting. Use these to view how the iova stock price has trended and to identify notable highs and lows.
Notable price events
Material moves in the iova stock price commonly follow clinical trial readouts, FDA or regulatory decisions, company earnings/financial updates, or analyst coverage changes.
Financial fundamentals and filings
Key fundamentals that affect investor valuation of Iovance include revenue, net income/loss, EPS, and cash and short-term investments. Official values are reported in SEC filings (10-Q, 10-K, 8-K) and summarized on sites like Yahoo Finance and Seeking Alpha.
Trading characteristics
Liquidity (average volume and bid-ask spreads), volatility (ATR, options implied volatility where available), and ownership mix (institutional vs retail, short interest) are all relevant when monitoring the iova stock price.
Analyst coverage and price targets
Analyst ratings and target prices published by platforms such as Finviz and Seeking Alpha can influence the iova stock price; consensus metrics should be checked on those pages for context.
News, events and catalysts
Clinical updates, regulatory filings, earnings reports and corporate announcements are primary catalysts. As of 2026-01-27,据 Yahoo Finance 报道 the company’s quote pages list market cap and volume fields for immediate reference; always verify details on the original source or filings.
Regulatory, legal and sector risks
Biotech-specific risks that affect the iova stock price include clinical trial setbacks, regulatory rejections, safety concerns, reimbursement issues and litigation.
How to find and interpret live quotes
Real-time execution prices are available through brokerage platforms; retail portals (Google Finance, Yahoo Finance, MarketWatch, Barchart) may display delayed or near-real-time quotes. For market tools and trading features, consider Bitget’s platform and Bitget Wallet for related account services and data (verify equities trading availability with your broker).
Investing and trading considerations (informational)
Investors typically combine fundamental review of filings and pipeline with technical charting and a regulatory event calendar when evaluating the iova stock price. This overview is informational and not investment advice.
See also
- Tumor-infiltrating lymphocyte (TIL) therapy
- FDA approval process for biologics
- Peer biotech tickers for comparison
References and data sources
Primary public data sources for the iova stock price and company information include: Barchart, Finviz, Google Finance, MarketWatch, Seeking Alpha, FinancialContent and Yahoo Finance. Company SEC filings remain the authoritative financial disclosures.
External links
- Company investor relations page (Iovance Biotherapeutics investor relations)
- Quote pages: Google Finance, Yahoo Finance, MarketWatch, Barchart, Finviz, Seeking Alpha
Further exploration: monitor the iova stock price on the listed portals, review SEC filings for definitive figures, and use Bitget’s market tools to stay informed.
